Stock research
BBIO — BRIDGEBIO PHARMA INC
BBIO is reported by 10 tracked managers with $1.9B in visible reported value. This page connects ownership breadth, filing activity, and price context.
Stock research evidence
The latest visible filing snapshot is 2026 Q2. Values come from reported manager holdings; prices and 52-week context come from the latest available market quote.
- Tracked holders
- 10
- Reported value
- $1.9B
- Ownership breadth
- Not available
- Current price
- $72
Top reported managers
These managers have the largest visible reported positions in BBIO. Portfolio weight is measured within each manager's latest visible filing.
- Andreas Halvorsen2.1% of reported portfolio · $741.0M · Reduce · Filed Aug 14, 2026
- John Overdeck / David Siegel0.3% of reported portfolio · $351.7M · Add · Filed Aug 14, 2026
- Ken Griffin0.2% of reported portfolio · $280.0M · Add · Filed Aug 14, 2026
- David Shaw0.2% of reported portfolio · $270.6M · Add · Filed Aug 14, 2026
- Primecap0% of reported portfolio · $75.7M · Add · Filed Aug 14, 2026
Continue the research
Review the manager roster, compare this company with the most widely held stocks, or browse transparent screens built from the same filing-backed data.